Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.57 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.57 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.56 |
| ▸ | FLT3 | P36888 | 1/20 | 0.52 |
| ▸ | AGXT | P21549 | 1/20 | 0.51 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.51 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA3 | P07451 | 1/20 | 0.50 |
| ▸ | CA4 | P22748 | 1/20 | 0.50 |
| ▸ | CA6 | P23280 | 1/20 | 0.50 |
| ▸ | MAOB | P27338 | 1/20 | 0.50 |
| ▸ | CA5A | P35218 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7171559 | 0.87 | ESR1 (0.59) | ESR1ESR2LOXL2FLT3AGXT | |
| SCHEMBL8036021 | 0.84 | ESR1 (0.56) | ESR1ESR2LOXL2FLT3AGXT | |
| SCHEMBL1259332 | 0.84 | ESR1 (0.56) | ESR1ESR2LOXL2FLT3AGXT | |
| SCHEMBL5986670 | 0.84 | LOXL2 (0.59) | ESR1ESR2LOXL2FLT3AGXT | |
| SCHEMBL7800851 | 0.84 | ESR1 (0.56) | ESR1ESR2LOXL2FLT3AGXT | |
| SCHEMBL7248298 | 0.82 | LOXL2 (0.53) | ESR1ESR2LOXL2FLT3AGXT | |
| SCHEMBL11708086 | 0.82 | ESR1 (0.55) | ESR1ESR2LOXL2FLT3AGXT | |
| SCHEMBL11101351 | 0.81 | ESR1 (0.54) | ESR1ESR2LOXL2FLT3AGXT | |
| SCHEMBL3131445 | 0.80 | ESR1 (0.52) | ESR1ESR2LOXL2FLT3AGXT | |
| SCHEMBL22013509 | 0.80 | ESR1 (0.52) | ESR1ESR2LOXL2FLT3AGXT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 226 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120131475-A | Preparation method and application of high-viscosity full-biological polysaccharide composite gel daily chemical thickener | 合肥艾普拉斯环保科技有限公司 | 2025-06-13 | — | — | CN | claimed |
| CN-119039727-A | Green multiple slow-release biological dispersion glue, preparation method and application | 中国石油天然气股份有限公司 | 2024-11-29 | — | — | CN | claimed |
| CN-112939748-A | Method for preparing deuterated compound through decarboxylation and deuteration of carboxylic acid | 中国科学院大连化学物理研究所 | 2021-06-11 | — | — | CN | claimed |
| EP-1904502-B1 | ANTIARRHYTHMIC PRECURSOR COMPOUNDS, METHODS OF SYNTHESIS AND METHODS OF USE | ARYX THERAPEUTICS INC (US) | 2009-10-21 | — | — | EP | claimed |
| US-7498449-B2 | Antiarrhythmic precursor compounds, methods of synthesis and methods of use | ARYX THERAPEUTICS (US) | 2009-03-03 | — | — | US | claimed |
| EP-1904502-A2 | ANTIARRHYTHMIC PRECURSOR COMPOUNDS, METHODS OF SYNTHESIS AND METHODS OF USE | Aryx Therapeutics, Inc. (US) | 2008-04-02 | — | — | EP | claimed |
| US-20070060640-A1 | Antiarrhythmic Precursor Compounds, Methods Of Synthesis And Methods Of Use | ARYX THERAPEUTICS (US) | 2007-03-15 | — | — | US | claimed |
| WO-2007011835-A2 | ANTIARRHYTHMIC PRECURSOR COMPOUNDS, METHODS OF SYNTHESIS AND METHODS OF USE | ARYX THERAPEUTICS, INC. (US) | 2007-01-25 | — | — | WO | claimed |
| EP-0446809-A1 | New process for the synthesis of 5-acyloxy and 5-alkoxy-2,3-dihydro-4,6,7-trimethyl-2-(RS)-benzofuranacetic acids | BIOMEDICA FOSCAMA INDUSTRIA CHIMICO-FARMACEUTICA S.P.A. (IT) | 1991-09-18 | — | — | EP | claimed |
| JP-52010259-A | — | — | None | — | — | JP | disclosed |
| JP-52010260-A | — | — | None | — | — | JP | disclosed |
| JP-52010257-A | — | — | None | — | — | JP | disclosed |
| JP-52010258-A | — | — | None | — | — | JP | disclosed |
| US-20250290137-A1 | SUBSTITUTED COUMARIN DYES AND USES AS FLUORESCENT LABELS | ILLUMINA CAMBRIDGE LIMITED (GB) | 2025-09-18 | — | — | US | disclosed |
| US-4126625-A | ANTIPHLOGISTIC, ANALGESIC | KYOWA HAKKO KOGYO KABUSHIKI KAISHA (JP) | 1978-11-21 | — | — | US | disclosed |
| US-4104396-A | NEUROLEPTIC, ANALGESIC | CIBA-GEIGY CORPORATION (US) | 1978-08-01 | — | — | US | disclosed |
| JP-S5210259-A | PREPARATION OF BENZOFURAN DERIVATIVES | KYOWA HAKKO KOGYO CO LTD | 1977-01-26 | — | — | JP | disclosed |
| JP-S5210257-A | PREPARATION OF BENZOFURAN DERIVATIVES | KYOWA HAKKO KOGYO CO LTD | 1977-01-26 | — | — | JP | disclosed |
| JP-S5210260-A | PREPARATION OF BENZOFURAN DERIVATIVES | KYOWA HAKKO KOGYO CO LTD | 1977-01-26 | — | — | JP | disclosed |
| JP-S5210258-A | PREPARATION OF BENZOFURAN DERIVATIVES | KYOWA HAKKO KOGYO CO LTD | 1977-01-26 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250290137-A1 | SUBSTITUTED COUMARIN DYES AND USES AS FLUORESCENT LABELS | FBL, DUT, PHAX | ESR1 1486/4885ESR2 2668/4885LOXL2 2375/4885 |
| US-20070060640-A1 | Antiarrhythmic Precursor Compounds, Methods Of Synthesis And Methods Of Use | SCN11A, SCN10A, CYP4F11 | ESR1 1700/4885ESR2 1069/4885LOXL2 4823/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.